Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia

Objectives: To evaluate the efficacy of intravitreal bevacizumab treatment in type 2 idiopathic macular telangiectasia (IMT). Materials and Methods: Six eyes of 5 patients with type 2 IMT who received intravitreal bevacizumab between 2009 and 2014 were included in this study. All the patients had a...

Full description

Bibliographic Details

Published in:	Türk Oftalmoloji Dergisi
Main Authors:	Tuğba Aydoğan, Gürkan Erdoğan, Cihan Ünlü, Ahmet Ergin
Format:	Article
Language:	English
Published:	Turkish Ophthalmology Society 2016-12-01
Subjects:	Type 2 idiopathic macular telangiectasia intravitreal bevacizumab macular edema
Online Access:	http://www.oftalmoloji.org/article_12561/Intravitreal-Bevacizumab-Treatment-In-Type-2-Idiopathic-Macular-Telangiectasia